<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.0 20120330//EN" "http://jats.nlm.nih.gov/publishing/1.0/JATS-journalpublishing1.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" article-type="article-commentary" dtd-version="1.0" xml:lang="en">
<front>
<journal-meta>
<journal-id journal-id-type="issn">1043-3155</journal-id>
<journal-id journal-id-type="nlm-ta">Pediatr Neurol Briefs</journal-id>
<journal-id journal-id-type="pmc">pedneurbriefs</journal-id>
<journal-id journal-id-type="iso-abbrev">Pediatr Neurol Briefs</journal-id>
<journal-title-group>
<journal-title>Pediatric Neurology Briefs</journal-title>
<abbrev-journal-title>Pediatr Neurol Briefs</abbrev-journal-title>
</journal-title-group>
<issn pub-type="epub">2166-6482</issn>
<issn pub-type="ppub">1043-3155</issn>
<issn-l>2166-3155</issn-l>
<publisher>
<publisher-name>Pediatric Neurology Briefs Publishers</publisher-name>
<publisher-loc>Chicago, IL, USA</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="publisher-id">PNB-17-08-a</article-id>
<article-id pub-id-type="doi">10.15844/pedneurbriefs-17-1-10</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Seizure Disorders</subject>
</subj-group>
<subj-group subj-group-type="Discipline-v2">
<subject>Neurology</subject>
<subject>Pediatrics</subject>
<subject>Nervous System Diseases</subject>
<subject>Child Development</subject>
<subject>Brain Diseases</subject>
<subject>Neurosurgery</subject>
<subject>Child</subject>
<subject>Infant</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Epilepsy and Fragile X Syndrome</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" corresp="yes">
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-0173-7931</contrib-id>
<name>
<surname>Millichap</surname>
<given-names>J. Gordon</given-names>
</name>
<degrees>MD</degrees>
<xref ref-type="aff" rid="AF0001">1</xref>
<xref ref-type="aff" rid="AF0002">2</xref>
<xref ref-type="corresp" rid="cor1">&#x002A;</xref>
</contrib>
</contrib-group>
<aff id="AF0001">
<label>1</label>Division of Neurology, Children&#x0027;s Memorial Hospital, Chicago, IL</aff>
<aff id="AF0002">
<label>2</label>Departments of Pediatrics and Neurology, Northwestern University Feinberg School of Medicine, Chicago, IL</aff>
<author-notes>
<corresp id="cor1"><label>&#x002A;</label>Correspondence: Dr. J. Gordon Millichap, E-mail: <email xlink:href="jgmillichap@northwestern.edu">jgmillichap@northwestern.edu</email>
</corresp>
</author-notes>
<pub-date date-type="pub" publication-format="print">
<month>01</month>
<year>2003</year>
</pub-date>
<pub-date date-type="pub" publication-format="electronic">
<day>01</day>
<month>03</month>
<year>2016</year>
</pub-date>
<volume>17</volume>
<issue>1</issue>
<fpage>8</fpage>
<lpage>8</lpage>
<permissions>
<copyright-statement>Copyright: &#x00A9; 2003 The Author(s)</copyright-statement>
<copyright-year>2003</copyright-year>
<license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/4.0/">
<license-p>This work is licensed under the <uri xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution 4.0 International License</uri>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p>
</license>
</permissions>
<related-article id="R1" related-article-type="commentary-article" ext-link-type="doi" xlink:href="10.1111/j.1469-8749.2002.tb00277.x" vol="44" page="724">
<article-title>Epilepsy in fragile X syndrome</article-title>
</related-article>
<abstract abstract-type="web-summary" specific-use="electronic-only">
<p>The seizure history of 136 patients with fragile X syndrome (FXS), (age range 2 to 51 years; 113 males and 23 females), were reviewed at RUSH-Presbyterian-St Luke&#x2019;s Medical Center, Chicago, IL.</p>
</abstract>
<kwd-group>
<kwd>Fragile X Syndrome</kwd>
<kwd>Benign Rolandic Epilepsy</kwd>
<kwd>Retardation Protein</kwd>
</kwd-group>
</article-meta>
</front>
<body>
<p>The seizure history of 136 patients with fragile X syndrome (FXS), (age range 2 to 51 years; 113 males and 23 females), were reviewed at RUSH-Presbyterian-St Luke&#x2019;s Medical Center, Chicago, IL. Seizures occurred in 13.3% of males with FXS and 4.3% of females; and the majority were partial seizures. Epileptiform EEGs were found in 77% individuals with seizures and 23% of those without, most commonly centrotemporal spikes. Seizures were easily controlled in 14 of 16 treated. Benign rolandic epilepsy was the most common epilepsy syndrome in FXS patients, all of whom showed remission. A specific relation between absence of fragile X mental retardation protein and benign rolandic epilepsy with centrotemporal spikes is suggested. [<xref ref-type="bibr" rid="CIT0001">1</xref>]</p>
<p>COMMENT. Complex partial seizures are the most common seizure type and benign rolandic epilepsy with centrotemporal spikes in the EEG the most common epilepsy syndrome in patients with fragile X syndrome. Seizures in FXS are easily controlled with anticonvulsants and are usually limited to childhood. Seizures are less frequent in girls with FXS than in boys, attesting to the milder phenotypic manifestations of FXS in girls.</p>
<p><bold>Fragile X carrier state may underlie a diagnosis of essential tremor</bold> in older male patients, according to a report of 2 fragile X carriers (ages 68 and 63 years) seen at the University of Colorado, Denver, and University of Toronto, Ontario [<xref ref-type="bibr" rid="CIT0002">2</xref>]. In addition to a disabling intention tremor, the patients had impaired tandem gait, generalized brain atrophy with frontal psychological deficits, and T2 middle cerebellar hyperintensities on MRI. Both had elevated FXMR gene 1 messenger RNA and reduced FXMR 1 protein.</p>
</body>
<back>
<ref-list>
<ref id="CIT0001">
<label>1</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Berry-Kravis</surname>
<given-names>E</given-names>
</name>
</person-group>
<article-title>Epilepsy in fragile X syndrome</article-title>
<source>Dev Med Child Neurol</source>
<year>2002</year>
<month>Nov</month>
<volume>44</volume>
<issue>11</issue>
<fpage>724</fpage>
<lpage>8</lpage>
<pub-id pub-id-type="doi">10.1111/j.1469-8749.2002.tb00277.x</pub-id>
<pub-id pub-id-type="pmid">12418611</pub-id>
</element-citation>
</ref>
<ref id="CIT0002">
<label>2</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Leehey</surname>
<given-names>MA</given-names>
</name>
<name>
<surname>Munhoz</surname>
<given-names>RP</given-names>
</name>
<name>
<surname>Lang</surname>
<given-names>AE</given-names>
</name>
<name>
<surname>Brunberg</surname>
<given-names>JA</given-names>
</name>
<name>
<surname>Grigsby</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Greco</surname>
<given-names>C</given-names>
</name>
<etal/>
</person-group>
<article-title>The fragile X premutation presenting as essential tremor</article-title>
<source>Arch Neurol</source>
<year>2003</year>
<month>Jan</month>
<volume>60</volume>
<issue>1</issue>
<fpage>117</fpage>
<lpage>21</lpage>
<pub-id pub-id-type="doi">10.1001/archneur.60.1.117</pub-id>
<pub-id pub-id-type="pmid">12533098</pub-id>
</element-citation>
</ref>
</ref-list>
</back>
</article>